TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31295558

Group type: EXPERIMENTAL
Intervention: NO3‐‐rich beetroot juice (BJ) after rinsing with water
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: NO3‐‐rich beetroot juice (BJ) after rinsing with antibacterial mouthwash
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salivary test strips (Berkeley Test strips)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salivary sialin concentrations
Number of subjects: 10
Study: 28586628

Group type: EXPERIMENTAL
Intervention: Radial Extracorporeal Shock Wave Therapy (rESWT) combined with supervised exercises
Number of subjects: 143

Group type: COMPARATOR
Intervention: Sham Radial Extracorporeal Shock Wave Therapy combined with supervised exercises
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Radial Extracorporeal Shock Wave Therapy (rESWT) in patients with calcification in rotator cuff
Number of subjects: 143
Study: 26248619

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 1879
Study: 23923693

Group type: EXPERIMENTAL
Intervention: Spring-loaded crutches
Number of subjects: 7

Group type: COMPARATOR
Intervention: Standard crutches
Number of subjects: 7
Study: 22011856

Group type: EXPERIMENTAL
Intervention: Soybean-treated group (12.95 g of soy protein for 90 days)
Number of subjects: 40
Study: 19801931

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication (CNF)
Number of subjects: 148
Study: 16416230

Group type: EXPERIMENTAL
Intervention: Mesalamine (2.4 g/day; n = 9)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (n = 4)
Number of subjects: 13
Study: 15180141

Group type: COMPARATOR
Intervention: 0.5% ketorolac tromethamine plus placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.5% ketorolac tromethamine plus 1% prednisolone acetate
Number of subjects: 10
Study: 11405194

Group type: EXPERIMENTAL
Intervention: Statins (specific dosage and duration not mentioned)
Number of subjects: 0
Study: 9788006

Group type: EXPERIMENTAL
Intervention: Growth hormone releasing hormone (GHRH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apomorphine (APO)
Number of subjects: 0
Study: 8012861

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide nasal spray (42 micrograms/nostril)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide nasal spray (168 micrograms/nostril)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 24
Study: 2557947

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine 60 mg plus ibuprofen 200 mg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine 60 mg alone
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 1195153

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Will power
Number of subjects: 43

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Behavior therapy (maintenance follow-up)
Number of subjects: 43
Study: 29890366

Group type: EXPERIMENTAL
Intervention: Metacognitive Training for Depression (D-MCT)
Number of subjects: 0
Study: 28124231

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 138
Study: 25893930

Group type: EXPERIMENTAL
Intervention: Lycopene 35 mg, selenium 55 µg, and green tea catechins 600 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lycopene, GTCs, and selenium supplementation
Number of subjects: 60
Study: 24090777

Group type: EXPERIMENTAL
Intervention: Prenatal exposure to antiepileptic drugs (AED)
Number of subjects: 1630

Group type: EXPERIMENTAL
Intervention: No AED treatment during pregnancy
Number of subjects: 1630

Group type: COMPARATOR
Intervention: No epilepsy (control group)
Number of subjects: 1630
Study: 21470320

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 18325646

Group type: EXPERIMENTAL
Intervention: Weighting the unaffected leg during treadmill walking
Number of subjects: 10
Study: 17140280

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg oral tablet
Number of subjects: 334
Study: 12830602

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 20 micrograms 2-hourly to a maximum of four doses (80 micrograms)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 25 micrograms in the posterior fornix
Number of subjects: 396

Group type: COMPARATOR
Intervention: Dinoprostone 1 mg inserted in the posterior fornix and repeated 6-hourly to a maximum of three doses
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Misoprostol (both oral and vaginal)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 396

Group type: COMPARATOR
Intervention: Dinoprostone
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 396
Study: 10319823

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 23
Study: 9125276

Group type: EXPERIMENTAL
Intervention: Transdermal Patch (Dermestril 50, 4 mg E2, delivers 50 micrograms E2 daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral Tablet (2 mg micronized E2, daily administration)
Number of subjects: 32
Study: 2103761

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study: 6769155

Group type: EXPERIMENTAL
Intervention: Cromoglycate (DSCG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 31511682

Group type: EXPERIMENTAL
Intervention: Randomly generated experiments
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Machine-learning models trained on smaller randomized reaction dataset
Number of subjects: 548
Study: 28697253

Group type: EXPERIMENTAL
Intervention: Switch to bupropion (n=511)
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: Augment current treatment with bupropion (n=506)
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: Augment with aripiprazole (n=505)
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Augment with bupropion (n=506)
Number of subjects: 1522
Study: 25549192

Group type: EXPERIMENTAL
Intervention: Volume Expansion (HV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Augmented Blood Pressure (ABP)
Number of subjects: 20
Study: 24692475

Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2-3)
Number of subjects: 973

Group type: COMPARATOR
Intervention: Aspirin (75 mg/d)
Number of subjects: 973
Study: 22179601

Group type: EXPERIMENTAL
Intervention: Landiolol (group L, n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nontreated (group N, n = 32)
Number of subjects: 64
Study: 20437641

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening programme (2007-2008)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening programme
Number of subjects: 6000
Study: 17364234

Group type: EXPERIMENTAL
Intervention: OSI-7904L 12 mg/m2 intravenously every 21 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: 5-FU/LV (intravenous l-LV 200 mg/m2, bolus 5-FU 400 mg/m2 and a 46-h infusion of 5-FU 2,400 mg/m2) every 14 days
Number of subjects: 22
Study: 16291062

Group type: EXPERIMENTAL
Intervention: Ertapenem (1 g daily; n=295)
Number of subjects: 586
Study: 12122922

Group type: EXPERIMENTAL
Intervention: Intravenous administration of ketamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of a weak opioid and an NMDA-receptor antagonist
Number of subjects: 0
Study: 10037348

Group type: EXPERIMENTAL
Intervention: Q-switched Alexandrite (QS Alex) laser
Number of subjects: 33

Group type: COMPARATOR
Intervention: Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) laser
Number of subjects: 33
Study: 8560901

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day (LDL < 195 mg/dl) or 20 mg/day (LDL > 195 mg/dl)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bezafibrate 600 mg/day
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bezafibrate
Number of subjects: 64
Study: 3389862

Group type: EXPERIMENTAL
Intervention: 4 IU growth hormone three days a week (group 1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 2 IU six days a week (group 2)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1 IU twice daily six days a week (group 3)
Number of subjects: 42
Study: 31407230

Group type: EXPERIMENTAL
Intervention: Eribulin plus gemcitabine (EG)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Paclitaxel plus gemcitabine (PG)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Mutation signature 3
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Mutation signature 3 (low vs. high)
Number of subjects: 119
Study: 28181206

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (Symfona® forte 120 mg) twice-daily for 6 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 50
Study: 26163170

Group type: EXPERIMENTAL
Intervention: E-cigarette TV advertisements
Number of subjects: 3655
Study: 23405025

Group type: EXPERIMENTAL
Intervention: Wristwatch cueing device over the hemiplegic arm for three hours a day, five days per week, for three weeks, plus conventional rehabilitation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham device with the same rehabilitation process
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Wristwatch cueing device
Number of subjects: 40
Study: 21381497

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intra-articular injection of hyaluronic acid products
Number of subjects: 2343
Study: 18156154

Group type: EXPERIMENTAL
Intervention: Robot-based hand motor therapy emphasizing intense active movement repetition, attention, speed, force, precision, and timing, including virtual reality games for 3 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Robotic assistance in all sessions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grasp task practiced during robotic therapy.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-practiced task, supination/pronation.
Number of subjects: 0
Study: 20958896

Group type: EXPERIMENTAL
Intervention: Handwashing promotion with free soap
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Handwashing promotion with free waterless hand sanitizer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 30
Study: 17564407

Group type: EXPERIMENTAL
Intervention: Motivated to appear as sleepy as possible during MSLT
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Motivated to be wakeful during MWT
Number of subjects: 12
Study: 12243016

Group type: EXPERIMENTAL
Intervention: BPTB allograft (Tutoplast)
Number of subjects: 268

Group type: COMPARATOR
Intervention: BPTB autograft
Number of subjects: 268
Study: 9484356

Group type: EXPERIMENTAL
Intervention: NSAID use
Number of subjects: 2651

Group type: EXPERIMENTAL
Intervention: Anti-indigestion drug use
Number of subjects: 2651
Study: 8057411

Group type: EXPERIMENTAL
Intervention: Trazodone (150 mg to 200 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 35
Study: 3246169

Group type: EXPERIMENTAL
Intervention: 50 mg/kg ceftriaxone (single dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50 mg/kg ceftriaxone (3 consecutive days)
Number of subjects: 60
Study: 11747665

Group type: EXPERIMENTAL
Intervention: Telegenetic consultation via videoconferencing
Number of subjects: 33

Group type: COMPARATOR
Intervention: Face-to-face conventional clinic (control)
Number of subjects: 33
Study: 31354153

Group type: EXPERIMENTAL
Intervention: New technique (asymmetric sinus excision with additional skin excision)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard Karydakis technique
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 29504676

Group type: EXPERIMENTAL
Intervention: Semielevated side‐lying (ESL) position
Number of subjects: 80

Group type: COMPARATOR
Intervention: Semielevated supine (ESU) position
Number of subjects: 80
Study: 27384040

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) combined with conventional scaling and root planing (SRP)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional scaling and root planing (SRP) alone
Number of subjects: 13
Study: 25206313

Group type: EXPERIMENTAL
Intervention: Tracheal orifice-covered (TOC) group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Tracheal orifice-exposed (TOE) group
Number of subjects: 66
Study: 22222052

Group type: EXPERIMENTAL
Intervention: IFN α-2a (180 μg once weekly) + weight-based RBV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IFN α-2b (1.5 μg/kg once weekly) + weight-based RBV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 20
Study: 20061999

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control (CNI-based immunosuppression)
Number of subjects: 282
Study: 17379017

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15 mg/d)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Voglibose (0.6 mg/d)
Number of subjects: 39
Study: 15308513

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 222

Group type: COMPARATOR
Intervention: Paracetamol 1000 mg
Number of subjects: 222
Study: 11136283

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9851955

Group type: EXPERIMENTAL
Intervention: Abciximab plus low-dose heparin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard-dose heparin
Number of subjects: 200
Study: 7988579

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 80
Study: 3056085

Group type: EXPERIMENTAL
Intervention: Fibraccel (50-ml infusions lasting 30 min each, started immediately after antagonism by protamine chloride, followed by subsequent 50-ml infusions every 4 h until 20 h after extracorporeal circulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo infusions at corresponding times
Number of subjects: 40
Study: 30168511

Group type: EXPERIMENTAL
Intervention: Combined physiotherapy including treatment in the spa capsule (n=29)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Local vacuum therapy (n=28)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation therapy (n=29)
Number of subjects: 86
Study: 28619175

Group type: EXPERIMENTAL
Intervention: Sodium oxybate 4.5g
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Sodium oxybate 6g
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Sodium oxybate 9g
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 25877694

Group type: EXPERIMENTAL
Intervention: Minimally invasive direct anterior approach
Number of subjects: 163

Group type: COMPARATOR
Intervention: Direct lateral approach
Number of subjects: 163
Study: 22879452

Group type: EXPERIMENTAL
Intervention: Video group (received video and GPS feedback)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Education group (classroom-based course)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 54
Study: 21946134

Group type: EXPERIMENTAL
Intervention: Combined microcurrent reflexotherapy (MCRT) and cortexin
Number of subjects: 78

Group type: COMPARATOR
Intervention: Microcurrent reflexotherapy (MCRT) only
Number of subjects: 78
Study: 18710330

Group type: EXPERIMENTAL
Intervention: Restorative yoga intervention (15 sessions of 90 minutes each over 10 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study: 16536957

Group type: EXPERIMENTAL
Intervention: Immediate antibiotics
Number of subjects: 315

Group type: COMPARATOR
Intervention: Delayed prescribing (at parents' discretion)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Prior episodes of AOM
Number of subjects: 315
Study: 14574032

Group type: EXPERIMENTAL
Intervention: Implanted defibrillators
Number of subjects: 4

Group type: COMPARATOR
Intervention: Pharmacologic antiarrhythmic therapy
Number of subjects: 4
Study: 10225168

Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg kg‐1
Number of subjects: 61

Group type: COMPARATOR
Intervention: Fentanyl 1.5 micrograms kg‐1
Number of subjects: 61
Study: 8903382

Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg/d, 5 days per week) + UDCA (13-15 mg x kg(‐1) x day(‐1))
Number of subjects: 74

Group type: COMPARATOR
Intervention: UDCA alone (placebo)
Number of subjects: 74
Study: 1864448

Group type: EXPERIMENTAL
Intervention: 150 mg/day diclofenac potassium for 7 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.2 g/day ibuprofen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6350471

Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 30472141

Group type: EXPERIMENTAL
Intervention: Active intranasal stimulation
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: ITN stimulation
Number of subjects: 145

Group type: COMPARATOR
Intervention: Extranasal stimulation (active control)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Sham intranasal stimulation (inactive control)
Number of subjects: 145
Study: 27797421

Group type: EXPERIMENTAL
Intervention: Sonic cleansing brush (normal speed)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual cleansing
Number of subjects: 20
Study: 27083135

Group type: EXPERIMENTAL
Intervention: 1% dextrose in Ringer lactate (RL) at 10 ml·kg(‐1) ·h(‐1) (Group D1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2% dextrose in Ringer lactate (RL) at 10 ml·kg(‐1) ·h(‐1) (Group D2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 10% dextrose in N/5 saline at 4 ml·kg(‐1) ·h(‐1) and replacement fluid with 6 ml·kg(‐1) ·h(‐1) of RL (Group D4)
Number of subjects: 45
Study: 25096822

Group type: EXPERIMENTAL
Intervention: Lactose solution (25 g)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Saccharose placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Lactose intolerance defined as SS ≥ 6 points after subtracting placebo effect
Number of subjects: 121
Study: 22621727

Group type: EXPERIMENTAL
Intervention: Parent Training (PT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 62
Study: 19246722

Group type: EXPERIMENTAL
Intervention: Ketoconazole + Midazolam on Day 5
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketoconazole + Midazolam on Day 2
Number of subjects: 0
Study: 17617338

Group type: EXPERIMENTAL
Intervention: Critical pathway implementation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Standardization of surgical techniques
Number of subjects: 90

Group type: COMPARATOR
Intervention: Single vendor implant selection
Number of subjects: 90
Study: 15222511

Group type: EXPERIMENTAL
Intervention: Oral micronized progesterone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone
Number of subjects: 60
Study: 12460330

Group type: EXPERIMENTAL
Intervention: IGF‐I levels in younger age group (20-44)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: IGF‐I levels in middle age group (45-59)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: IGF‐I levels in older age group (over 59 years)
Number of subjects: 288
Study: 10403710

Group type: EXPERIMENTAL
Intervention: Careful scrutiny of items at retrieval
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noticing specific differentiating perceptual features of the objects during encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encouraged to use more stringent decision criteria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both manipulations (careful scrutiny and noticing features)
Number of subjects: 0
Study: 7591555

Group type: EXPERIMENTAL
Intervention: Visual laser ablation of the prostate (VLAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transurethral resection (TURP)
Number of subjects: 0
Study: 2174320

Group type: EXPERIMENTAL
Intervention: Insulin infusion during euglycemia
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Insulin infusion during hyperglycaemia
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intralipid infusion during hyperinsulinaemia with euglycemia or hyperglycaemia
Number of subjects: 7
Study: 7239110

Group type: EXPERIMENTAL
Intervention: Starch enemas (10%; 1000 ml t.i.d.) plus neomycin tablets
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lactose enemas (20%; 1000 ml t.i.d.) plus placebo tablets
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (starch enemas plus neomycin tablets)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (lactose enemas plus placebo tablets)
Number of subjects: 18
Study: 30709694

Group type: EXPERIMENTAL
Intervention: LED light irradiation from initial clinical assessment (T0) until the completion of scaling and root planning (T1) (LED01)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: LED light irradiation from T1 until re-evaluation (T2) (LED02)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control treatment (no LED light irradiation)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 19
Study: 29565642

Group type: EXPERIMENTAL
Intervention: MACI (Matrix‐Applied Characterized Autologous Cultured Chondrocytes)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Microfracture
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: MRI evaluation for both treatments
Number of subjects: 144